Hemodialysis membranes for high-volume hemodialytic therapies: The application of nanotechnology

Hemodialysis International

Volumn 10, Issue SUPPL. 1, 2006, Pages

  Ronco, Claudio ^a   Breuer, Bernd ^b   Bowry, Sudhir K ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; POLYSULFONE; UREMIC TOXIN;

ANEMIA; ARTICLE; ARTIFICIAL KIDNEY; BONE DISEASE; CARDIOVASCULAR DISEASE; DIALYSIS MEMBRANE; DIFFUSION; HEMODIAFILTRATION; HEMODIALYSIS; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; MEMBRANE TRANSPORT; NANOTECHNOLOGY; NUTRITIONAL STATUS; SURVIVAL RATE; THERMODYNAMICS; TREATMENT OUTCOME; WATER QUALITY;

EQUIPMENT DESIGN; HUMANS; MEMBRANES, ARTIFICIAL; NANOTECHNOLOGY; RENAL DIALYSIS;

EID: 33144469313     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.01191.x     Document Type: Article

References (21)

1. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States; The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14:3270-3277.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(Suppl 3):S112-S119.
3. NIH Consensus Conference Statement. Mortality and morbidity of renal dialysis. Ann Intern Med. 1994; 121:62-70.
4. Weissinger E, Kaiser T, Meert N, et al. Proteomics: A novel tool to unravel the pathophysiology of uraemia. Nephrol Dial Transplant. 2004.
5. Boure T, Vanholder R. Biochemical and clinical evidence for uremic toxicity. Artif Organs. 2004; 28:248-253.
6. Ledebo I. Principles and practice of hemofiltration and hemodiafiltration. Artif Organs. 1998; 22:20-25.
7. Maduell F. Hemodiafiltration. Hemodial Int. 2005; 9:47-55.
8. Canaud B, Bragg-Gresham JL, Marshall MR. Patients receiving hemodiafiltration or hemofiltration have lower mortality risk than patients receiving hemodialysis without replacement fluid (HD) in Europe: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14:31A.
9. Clark WR, Gao D. Properties of membranes used for hemodialysis therapy. Semin Dial. 2002; 15:191-195.
10. Bowry SK. Dialysis membranes today. Int J Artif Organs. 2002; 25:447-460.
11. Ronco C, Nissenson AR. Does nanotechnology apply to dialysis? Blood Purif. 2001; 19:347-352.
12. Ronco C, Bowry S. Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane. Int J Artif Organs. 2001; 24:726-735.
13. Bowry SK, Ronco C. Surface topography and surface elemental composition analysis of Helixone, a new high-flux polysulfone dialysis membrane. Int J Artif Organs. 2001; 24:757-7764.
14. Bonomini M, Ballone E, Di Stante S, et al. Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. Nephrol Dial Transplant. 2004; 19:68-74.
15. Bammens B, Evenepoel P, Verbeke K, et al. Removal of protein-bound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis. 2004; 44:278-285.
16. Ahrenholz PG, Winkler RE, Bowry SK, et al. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: The β2-microglobulin/albumin relationship. Clin Nephrol. 2004; 62:21-28.
17. Ronco C, Brendolan A, Lupi A, et al. Effects of a reduced inner diameter of hollow fibers in hemodialysers. Kidney Int. 2000; 58:809-817.
18. Ronco C, Orlandini G, Brendolan A. Enhancement of convective transport by internal filtration in a modified experimental hemodialyszer. Kidney Int. 1998; 54: 979-985.
19. Weber C, Groetsch W, Schlotter S. Novel online infusate-assisted dialysis system performs microbiologically safely. Artif Organs. 24:323-328.
20. Weber V, Linsberger I, Rossmanith E, et al. Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif Organs. 2004; 28:210-217.
21. Schindler R, Christ-Kohlrausch F, Frei U, Shaldon S. Differences in the permeability of high-flux dialyser membranes for bacterial pyrogens. Clin Nephrol. 2003; 59:447-454.